Largest biotech by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech ranked by earnings, at PLN 34.2B, ahead of Amgen (PLN 31B) and Biogen (PLN 5.2B). Figures as of 18 Nov 2026, 14:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesPLN 34.2B
- Median
- -PLN 275.7M
- Combined market value
- PLN 3.41T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | PLN 34.2B | PLN 848.9B | PLN 684.43 | 1.60% up | 33% up | ||
| 2 | AmgenAMGN · Health Care | PLN 31B | PLN 995.7B | PLN 1,840.83 | 0.95% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | PLN 5.2B | PLN 149B | PLN 1,008.15 | 0.34% down | 49% up | ||
| 4 | argenxARGX · Health Care | PLN 5.2B | PLN 239.5B | PLN 3,808.93 | 0.36% down | 4% up | ||
| 5 | ExelixisEXEL · Health Care | PLN 3.1B | PLN 67.2B | PLN 275.36 | 2.09% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | PLN 1.9B | PLN 67.5B | PLN 666.98 | 0.37% up | 20% up | ||
| 7 | QiagenQGEN · Health Care | PLN 1.7B | PLN 41.3B | PLN 199.99 | 0.12% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | PLN 1.3B | PLN 44B | PLN 385.79 | 0.55% down | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | PLN 823.4M | PLN 35.6B | PLN 1,200.14 | 0.22% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | PLN 731.1M | PLN 45.9B | PLN 291.96 | 0.22% down | 26% up | ||
| 11 | RepligenRGEN · Health Care | PLN 196.5M | PLN 41.7B | PLN 651.95 | 0.37% down | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -PLN 239.2M | PLN 18.5B | PLN 114.53 | 2.22% up | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -PLN 312.2M | PLN 30.7B | PLN 450.23 | 6.63% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -PLN 647.2M | PLN 28.3B | PLN 317.33 | 6.89% down | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -PLN 924.4M | PLN 25.4B | PLN 389.13 | 3.90% down | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -PLN 1.3B | PLN 41.7B | PLN 488.50 | 3.44% down | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -PLN 1.4B | PLN 26.8B | PLN 25.16 | 4.68% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -PLN 1.5B | PLN 22.1B | PLN 181.22 | 1.21% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -PLN 2B | PLN 27.6B | PLN 133.50 | 0.21% down | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -PLN 2.3B | PLN 15.7B | PLN 161.40 | 0.54% down | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -PLN 3.1B | PLN 37.8B | PLN 238.78 | 3.59% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -PLN 4.5B | PLN 141.5B | PLN 654.00 | 2.50% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -PLN 5.1B | PLN 84.6B | PLN 341.13 | 0.47% down | 16% down | ||
| 24 | ModernaMRNA · Health Care | -PLN 11.3B | PLN 336.4B | PLN 831.31 | 3.93% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0199 PLN).
Questions and answers
Which biotech rank first by earnings?
Gilead Sciences (PLN 34.2B), Amgen (PLN 31B) and Biogen (PLN 5.2B) are the top three of the 24 biotech ranked by earnings as of 18 Nov 2026, 14:08 UTC.
How many biotech are in this ranking?
24 are ranked by earnings.
What are these biotech worth together?
The 24 biotech ranked by earnings have a combined market value of PLN 3.41T as of 18 Nov 2026, 14:08 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.